Gelesis Holdings EPS - Earnings per Share 2021-2022 | GLS
Gelesis Holdings eps - earnings per share from 2021 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Gelesis Holdings Annual EPS |
| 2021 |
$-0.37 |
| 2020 |
$-0.69 |
| 2019 |
$0.00 |
| Gelesis Holdings Quarterly EPS |
| 2022-03-31 |
$-0.70 |
| 2021-12-31 |
$9.83 |
| 2021-09-30 |
$-0.41 |
| 2021-06-30 |
$-0.41 |
| 2021-03-31 |
$-9.38 |
| 2020-12-31 |
$0.00 |
| 2020-09-30 |
$0.00 |
| 2020-06-30 |
$0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.122B |
$0.011B |
|
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
|
